Sökning: onr:"swepub:oai:DiVA.org:liu-198659" >
Pleconaril and riba...
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial
-
- Krogvold, Lars (författare)
- Oslo Univ Hosp, Norway
-
- Mynarek, Ida Maria (författare)
- Oslo Univ Hosp, Norway
-
- Ponzi, Erica (författare)
- Oslo Univ Hosp, Norway
-
visa fler...
-
- Mork, Freja Barrett (författare)
- Copenhagen Univ Hosp, Denmark; Univ Copenhagen, Denmark
-
- Hessel, Trine Witzner (författare)
- Copenhagen Univ Hosp, Denmark
-
- Roald, Trine (författare)
- Oslo Univ Hosp, Norway
-
- Lindblom, Nina (författare)
- Apodemus AB, Sweden
-
- Westman, Jacob (författare)
- Apodemus AB, Sweden
-
- Barker, Peter (författare)
- Natl Inst Hlth & Care Res, England
-
- Hyoety, Heikki (författare)
- Tampere Univ, Finland; Fimlab Labs, Finland
-
- Ludvigsson, Johnny (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, H.K.H. Kronprinsessan Victorias barn- och ungdomssjukhus
-
- Hanssen, Kristian F. (författare)
- Univ Oslo, Norway
-
- Johannesen, Jesper (författare)
- Copenhagen Univ Hosp, Denmark
-
- Dahl-Jorgensen, Knut (författare)
- Oslo Univ Hosp, Norway; Univ Oslo, Norway
-
visa färre...
-
(creator_code:org_t)
- NATURE PORTFOLIO, 2023
- 2023
- Engelska.
-
Ingår i: Nature Medicine. - : NATURE PORTFOLIO. - 1078-8956 .- 1546-170X. ; 29, s. 2902-2908
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://liu.diva-por... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Previous studies showed a low-grade enterovirus infection in the pancreatic islets of patients with newly diagnosed type 1 diabetes (T1D). In the Diabetes Virus Detection (DiViD) Intervention, a phase 2, placebo-controlled, randomized, parallel group, double-blind trial, 96 children and adolescents (aged 6-15 years) with new-onset T1D received antiviral treatment with pleconaril and ribavirin (n = 47) or placebo (n = 49) for 6 months, with the aim of preserving beta cell function. The primary endpoint was the mean stimulated C-peptide area under the curve (AUC) 12 months after the initiation of treatment (less than 3 weeks after diagnosis) using a mixed linear model. The model used longitudinal log-transformed serum C-peptide AUCs at baseline, at 3 months, 6 months and 1 year. The primary endpoint was met with the serum C-peptide AUC being higher in the pleconaril and ribavirin treatment group compared to the placebo group at 12 months (average marginal effect = 0.057 in the linear mixed model; 95% confidence interval = 0.004-0.11, P = 0.037). The treatment was well tolerated. The results show that antiviral treatment may preserve residual insulin production in children and adolescent with new-onset T1D. This provides a rationale for further evaluating antiviral strategies in the prevention and treatment of T1D. European Union Drug Regulating Authorities Clinical Trials identifier: 2015-003350-41. Results from the DiViD Intervention, a phase 2 randomized, placebo-controlled trial, showed that antiviral treatment with pleconaril and ribavirin for 6 months resulted in higher endogenous insulin production in children and adolescents with new-onset type 1 diabetes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Krogvold, Lars
-
Mynarek, Ida Mar ...
-
Ponzi, Erica
-
Mork, Freja Barr ...
-
Hessel, Trine Wi ...
-
Roald, Trine
-
visa fler...
-
Lindblom, Nina
-
Westman, Jacob
-
Barker, Peter
-
Hyoety, Heikki
-
Ludvigsson, John ...
-
Hanssen, Kristia ...
-
Johannesen, Jesp ...
-
Dahl-Jorgensen, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Nature Medicine
- Av lärosätet
-
Linköpings universitet